A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Ascending Parallel-group Study of the Safety and Tolerability of REGN88 in Subjects With Rheumatoid Arthritis Receiving Concomitant Methotrexate.
Phase of Trial: Phase I
Latest Information Update: 11 Nov 2010
At a glance
- Drugs Sarilumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Pharmacodynamics
- 16 Nov 2009 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health, NCT01011959).
- 13 Nov 2009 Actual start date (December 2008), official title, actual patient number (60), location (USA), primary outcome, lead investigator (Radin A) and sanofi-aventis added as trial sponsor as reported by ClinicalTrials.gov.
- 21 Sep 2009 New trial record.